slotkoers
Shenzhen S.E.
00:00:00 28-06-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
13,57
CNY
|
+0,07%
|
|
-3,35%
|
-11,83%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
15.285
|
27.436
|
41.354
|
25.222
|
17.996
|
15.868
|
-
|
-
|
Bedrijfswaarde
1 |
15.285
|
27.436
|
41.354
|
25.222
|
17.996
|
15.868
|
15.868
|
15.868
|
K/w-verhouding
|
27,6
x
|
33,6
x
|
43,3
x
|
25,6
x
|
17,1
x
|
13
x
|
10,9
x
|
9,47
x
|
Dividendrendement
|
-
|
1,04%
|
0,81%
|
1,38%
|
2,05%
|
2,58%
|
3,1%
|
3,02%
|
Marktkapitalisatie/omzet
|
-
|
3,48
x
|
4,62
x
|
2,39
x
|
1,57
x
|
1,24
x
|
1,11
x
|
1,02
x
|
Bedrijfswaarde/omzet
|
-
|
3,48
x
|
4,62
x
|
2,39
x
|
1,57
x
|
1,24
x
|
1,11
x
|
1,02
x
|
Bedrijfswaarde/EBITDA
|
-
|
-
|
27,9
x
|
18,1
x
|
11,3
x
|
9,85
x
|
8,45
x
|
7,64
x
|
Bedrijfswaarde/FCF
|
-
|
-
|
-479
x
|
30,7
x
|
43,9
x
|
78,2
x
|
10
x
|
8,78
x
|
FCF Yield
|
-
|
-
|
-0,21%
|
3,26%
|
2,28%
|
1,28%
|
9,97%
|
11,4%
|
Price to Book
|
-
|
6,25
x
|
8,17
x
|
4,61
x
|
2,91
x
|
2,24
x
|
1,95
x
|
1,71
x
|
Aantal aandelen (in duizenden)
|
1.178.523
|
1.178.523
|
1.178.523
|
1.170.955
|
1.169.324
|
1.169.324
|
-
|
-
|
Referentieprijs
2 |
12,97
|
23,28
|
35,09
|
21,54
|
15,39
|
13,57
|
13,57
|
13,57
|
Datum van publicatie
|
11/03/20
|
11/03/21
|
9/03/22
|
9/03/23
|
7/03/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
-
|
7.880
|
8.943
|
10.545
|
11.474
|
12.789
|
14.338
|
15.611
|
EBITDA
1 |
-
|
-
|
1.482
|
1.393
|
1.591
|
1.611
|
1.878
|
2.077
|
Bedrijfsresultaat (EBIT)
1 |
-
|
969,7
|
1.119
|
1.012
|
1.220
|
1.405
|
1.662
|
1.914
|
Operationele Marge
|
-
|
12,31%
|
12,52%
|
9,59%
|
10,63%
|
10,99%
|
11,59%
|
12,26%
|
Resultaat voor belastingen (EBT)
1 |
-
|
961,2
|
1.114
|
1.012
|
1.205
|
1.401
|
1.655
|
1.904
|
Nettowinst (verlies)
1 |
-
|
816,7
|
955,6
|
989,2
|
1.055
|
1.231
|
1.466
|
1.688
|
Nettomarge
|
-
|
10,37%
|
10,69%
|
9,38%
|
9,2%
|
9,62%
|
10,22%
|
10,81%
|
WPA
2 |
0,4696
|
0,6930
|
0,8108
|
0,8425
|
0,9025
|
1,046
|
1,244
|
1,432
|
Free Cash Flow
1 |
-
|
-
|
-86,3
|
821,9
|
409,9
|
203
|
1.582
|
1.807
|
FCF-marge
|
-
|
-
|
-0,97%
|
7,79%
|
3,57%
|
1,59%
|
11,03%
|
11,57%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
58,98%
|
25,76%
|
12,6%
|
84,22%
|
87,01%
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
83,09%
|
38,84%
|
16,49%
|
107,93%
|
107,03%
|
Dividend per aandeel
2 |
-
|
0,2430
|
0,2850
|
0,2970
|
0,3160
|
0,3500
|
0,4200
|
0,4100
|
Datum van publicatie
|
11/03/20
|
11/03/21
|
9/03/22
|
9/03/23
|
7/03/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-86,3
|
822
|
410
|
203
|
1.582
|
1.807
|
ROE (netto-inkomsten/eigen vermogen)
|
20,2%
|
20,2%
|
19%
|
18,2%
|
17,5%
|
18,1%
|
17,9%
|
ROA (netto-inkomsten/totale activa)
|
-
|
11,5%
|
-
|
8,51%
|
9,55%
|
10,4%
|
10,7%
|
Totale activa
1 |
-
|
8.329
|
-
|
12.394
|
12.887
|
14.162
|
15.779
|
Nettoactief per aandeel
2 |
3,730
|
4,290
|
4,680
|
5,280
|
6,060
|
6,950
|
7,950
|
Cashflow per aandeel
2 |
0,9000
|
0,5200
|
1,130
|
0,8800
|
1,230
|
1,510
|
1,720
|
Capex
1 |
300
|
702
|
504
|
622
|
217
|
165
|
186
|
Capex/omzet
|
3,81%
|
7,85%
|
4,78%
|
5,42%
|
1,7%
|
1,15%
|
1,19%
|
Datum van publicatie
|
11/03/21
|
9/03/22
|
9/03/23
|
7/03/24
|
-
|
-
|
-
|
Laatste slotkoers
13,57
CNY Gemiddelde koersdoel
17,75
CNY Spread / Gemiddelde doel +30,80% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| -11,83% | 2,18 mld. | | +55,32% | 819 mld. | | -6,75% | 351 mld. | | +13,56% | 329 mld. | | +10,68% | 298 mld. | | +16,57% | 242 mld. | | +2,04% | 225 mld. | | +13,31% | 217 mld. | | +8,48% | 168 mld. | | -2,81% | 158 mld. |
Farmaceutische producten - Andere
|